CD79A and infection: Investigators have evaluated the BAL (bronchoalveolar lavage) and serum samples from vaccinated donors with or without prior infection history for the presence of IgA and IgG titers of mucosal and circulating antibodies against the Spike, RBD, and N (nucleocapsid) protein of SARS-CoV-2 [52].